Philip Bruggmann
Dados Biográficos
| ID | 7446476 |
|---|---|
| NOME | Philip Bruggmann |
| PRENOMES | Philip |
| SOBRENOME | Bruggmann |
| ASSINATURA | BRUGGMANN P |
| AFILIAÇÕES | Addiction Switzerland |
| ORCID | 0000-0002-0436-8895 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 18 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 18 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2008 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2023 |
| ÍNDICE H | 0 |
Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection
Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden
Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral
Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Direct-acting antiviral therapy for hepatitis C infection among people receiving opioid agonist treatment or heroin assisted treatment
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Elimination of hepatitis C virus infection among PWID
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
People who inject drugs (PWID) represent the core of the hepatitis C virus (HCV) epidemic in many countries. HCV transmission continues among PWID, despite evidence demonstrating that high coverage of combined harm reduction strategies, such as needle syringe programs (NSP) and opioid substitution treatment (OST), can be effective in reducing the risk of HCV transmission. Among infected individuals, HCV-related morbidity and mortality continues t…
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs
Prevalence of hepatitis C in a Swiss sample of men who have sex with men
Our findings suggest that in Switzerland, hepatitis C among MSM without diagnosed HIV is not more prevalent than in the general population. We found no evidence of elevated rates of sexual transmission of HCV among MSM without HIV-infection. Therefore, we currently see no reason for promoting HCV-testing among all MSM in Switzerland
An integrated model of care to counter high incidence of HIV and sexually transmitted diseases in men who have sex with men – initial analysis of service utilizers in Zurich
Since its first months of activity, the service achieved high levels of recognition, acceptance and demand in the MSM community. Contrary to common concepts of "testing clinics", the Checkpoint service provides post-exposure prophylaxis, HIV and STI treatment, psychological support and counselling and general medical care. It thus follows a holistic approach to health in the MSM community with the particular aim to serve as a "door opener" betwee…
Sem obras proeminentes nesta página.
An integrated model of care to counter high incidence of HIV and sexually transmitted diseases in men who have sex with men – initial analysis of service utilizers in Zurich
Since its first months of activity, the service achieved high levels of recognition, acceptance and demand in the MSM community. Contrary to common concepts of "testing clinics", the Checkpoint service provides post-exposure prophylaxis, HIV and STI treatment, psychological support and counselling and general medical care. It thus follows a holistic approach to health in the MSM community with the particular aim to serve as a "door opener" betwee…
Prevalence of hepatitis C in a Swiss sample of men who have sex with men
Our findings suggest that in Switzerland, hepatitis C among MSM without diagnosed HIV is not more prevalent than in the general population. We found no evidence of elevated rates of sexual transmission of HCV among MSM without HIV-infection. Therefore, we currently see no reason for promoting HCV-testing among all MSM in Switzerland
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
People who inject drugs (PWID) represent the core of the hepatitis C virus (HCV) epidemic in many countries. HCV transmission continues among PWID, despite evidence demonstrating that high coverage of combined harm reduction strategies, such as needle syringe programs (NSP) and opioid substitution treatment (OST), can be effective in reducing the risk of HCV transmission. Among infected individuals, HCV-related morbidity and mortality continues t…
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Elimination of hepatitis C virus infection among PWID
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Direct-acting antiviral therapy for hepatitis C infection among people receiving opioid agonist treatment or heroin assisted treatment
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland
Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection
Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden
Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral
Medicine (18 obras) · Hepatitis C virus research (17 obras) · Hepatitis C virus (13 obras) · Virus (13 obras) · Hepatitis C (12 obras) · Internal Medicine (12 obras) · HIV, Drug Use, Sexual Risk (10 obras) · Immunology (10 obras) · Hepatitis B Virus Studies (8 obras) · Liver Disease Diagnosis and Treatment (6 obras)